Logistics Company UTi Worldwide Inc. (NASDAQ:UTIW) said it had breached some debt covenants and would report a loss for the fourth quarter due to a weak air freight market, sending its shares down as much as 28 percent in early trading. UTi Worldwide Inc. (NASDAQ:UTIW) stock opened at $10.73 in last session, and closed at $9.84, while the day range of UTi Worldwide Inc. (NASDAQ:UTIW) stock is $9.76 – $10.83. The stock showed a positive weekly performance of -36.10%.
Halozyme Therapeutics logo Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its earnings data on Thursday. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.02, American Banking News.com reports. The company had revenue of $12.50 million for the quarter, compared to the consensus estimate of $21.80 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was down 42.7% on a year-over-year basis. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened at $15.40 in last session, and closed at $14.09 by losing -12.05%. The 52 week range of $5.03 – 18.18. Company’s market capitalization is $1.59B.
Shares of XOMA Corp (NASDAQ:XOMA) were the target of some unusual options trading on Wednesday. Investors bought 23,123 call options on the stock, Analyst Ratings. XOMA Corp (NASDAQ:XOMA) stock decreased -6.17% and finished the last session at $8.36. The EPS of the stock remained -0.80. Company’s market capitalization is $727.60M.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has earned a consensus recommendation of “Hold” from the thirteen brokerages that are presently covering the stock, Analyst Ratings Network reports. One equities research analyst has rated the stock with a sell rating and twelve have issued a hold rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $5.29. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock opened the session at $3.74, and closed the session at $3.50. The 52 week range of the Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock remained $2.26 – $9.41 and the day range was $3.44 – $3.75.